Silver nanoparticles: safety and efficiency for human health

Cover Page

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Over the past few decades, nanoparticles of metals, and in particular silver, with a diameter of less than 100 nm have significantly expanded their field of application for various biomedical purposes. So, silver nanoparticles have great potential in a wide range of applications as antimicrobial agents, coatings for biomedical products, carriers for drug delivery, bioengineering, since they have discrete physical properties and wide biochemical functionality. Studies have shown that the size, morphology, stability and properties (chemical and physical) of metal nanoparticles are strongly influenced by the conditions of the experiment, the kinetics of the interaction of metal ions with reducing agents and the adsorption processes of the stabilizer with metal nanoparticles. This review aims to analyze the use of silver nanoparticles in modern medicine based on data from domestic and foreign literature over the past five years. The study confirmed the high biological activity of drugs with nanoserebrum as anti-inflammatory, antimicrobial agents, antifungals, the presence of an inhibitory effect on protozoa, antioxidant and anticancer effects, and substantiated the relevance of use in bioengineering and dentistry. However, rapid advances and advances in technology have led to concerns about the potential risk associated with the use and application of silver nanoparticles to human health and the environment. Therefore, this review attempts to characterize and quantify the potential harmful effects of silver nanoparticles on the health of laboratory animals and humans, and focuses on ways to neutralize or reduce the toxic effects of silver nanoparticles on the human body.

Full Text

Restricted Access

About the authors

Yuliya A. Morozova

Novosibirsk State Pedagogical University

Author for correspondence.
Email: moroz243@yandex.ru
ORCID iD: 0000-0002-5433-0641

external student

Russian Federation, 28, Vilyuiskaya str, Novosibirsk., 630126

Dmitry S. Dergachev

Meditsinskie Sistemy Ltd

Email: angel_a_angel@icloud.com
ORCID iD: 0000-0002-2126-8984

general manager

Russian Federation, Saint Petersburg

Mikhail A. Subotyalov

Novosibirsk State Pedagogical University; Novosibirsk State University

Email: subotyalov@yandex.ru
ORCID iD: 0000-0001-8633-1254
SPIN-code: 9170-4604

MD, Dr. Sci. (Med.)

Russian Federation, 28, Vilyuiskaya str, Novosibirsk., 630126; 1, st. Pirogov, Novosibirsk, 630090

References

  1. Bekkeri S. A Review on Metallic Silver Nanoparticles. IOSR J Of Pharm. 2015;4(7):38–44. doi: 10.9790/3013-0407038044
  2. Zaporotskova IV. Nanotechnologies and nanomaterials: scientific, economic and political realia of the new century. Journal of Volgograd State University. Economics. 2015;1(30):18–29. (In Russ.) doi: 10.15688/jvolsu3.2015.1.2
  3. Grigor’ev MG, Babich LN. Ispol’zovanie nanochastits serebra protiv sotsial’no znachimykh zabolevanii. Molodoi uchenyi. 2015;(9):396–401. (In Russ.)
  4. Voeikova TA, Krest’yanova IN, Sakhibgaraeva LF, et al. Biosynthesis of silver sulfide nanoparticles by microscopic fungi. Aktual’naya biotekhnologiya. 2015;3(14):51–51. (In Russ.)
  5. Stanishevskaya IE, Stoinova AM, Marakhova AI, Stanishevskiy YaM. Silver nanoparticles: preparation and use for medical purposes. Drug development & registration. 2016;(1):66–69. (In Russ.)
  6. Mashrai A, Dar AM, Sherwani MA, et al. Biosynthesis of silver nanoparticles as a platform for biomedicinal application. J Nanosci Nanomed. 2018;2(1):25–33. doi: 10.2147/IJN.S72313
  7. Franci G, Falanga A, Galdiero S, et al. Silver nanoparticles as potential antibacterial agents. Molecules. 2015;20(5):8856–8874. doi: 10.3390/molecules20058856
  8. Khorrami S, Zarrabi A, Khaleghi M, et al. Selective cytotoxicity of green synthesized silver nanoparticles against the MCF-7 tumor cell line and their enhanced antioxidant and antimicrobial properties. Int J Nanomedicine. 2018;13:8013–8024. doi: 10.2147/IJN.S189295
  9. Tippayawat P, Phromviyo N, Boueroy P, Chompoosor А. Green synthesis of silver nanoparticles in aloe vera plant extract prepared by a hydrothermal method and their synergistic antibacterial activity. Peer J. 2016;4(10):2589. doi: 10.7717/peerj.2589
  10. Jafari A, Pourakba RL, Farhadi K, et al. Biological synthesis of silver nanoparticles and evaluation of antibacterial and antifungal properties of silver and copper nanoparticles. Turk J Biol. 2015;39:556–561. doi: 10.3906/biy-1406-81
  11. Dulta K, Avinash K, Pankaj K. Eco-friendly Synthesis of Silver Nanoparticles Using Carica Papaya Leaf Extract and Its Antibiogram Activity. International Conference on New Horizons in Green Chemistry & Technology (ICGCT), December 10, 2018. doi: 10.2139/ssrn.3298711
  12. Balu SK, Andra S, Kannan S, et al. Facile synthesis of Silver nanoparticles with medicinal grass and its biological assessment. Materials Letters. 2020;259:126900. doi: 10.1016/j.matlet.2019.126900
  13. Selvamuthumari J, Meenakshi S, Ganesan M, et al. Antibacterial and catalytic properties of silver nanoparticles loaded zeolite: green method for synthesis of silver nanoparticles using lemon juice as reducing agent. Nanosystems: physics, chemistry, mathematics. 2016;7(4):768–773. doi: 10.17586/2220-8054-2016-7-4-768-773
  14. Sacco P, Travan A, Borgogna M, et al. Silver-containing antimicrobial membrane based on chitosan-TPP hydrogel for the treatment of wounds. J Mater Sci Mater Med. 2015;26:128. doi: 10.1007/s10856-015-5474-7
  15. Zaharov AV, Khokhlov AL, Ergeshov AE. Silver nanoparticles in the solution of the problem of drug resistance in mycobacterium tuberculosis. The Russian Archives of Internal Medicine. 2017;7(3):188–199. (In Russ.) doi: 10.20514/2226-6704-2017-7-3-188-199
  16. Qais FA, Shafiq A, Khan HM, et al. Antibacterial Effect of Silver Nanoparticles Synthesized Using Murraya koenigii (L.) against Multidrug-Resistant Pathogens. Bioinorganic Chemistry and Applications. 2019;2019:11. doi: 10.1155/2019/4649506
  17. Deljou A, Goudarzi S. Green Extracellular Synthesis of the Silver Nanoparticles Using Thermophilic Bacillus Sp. AZ1 and its Antimicrobial Activity Against Several Human Pathogenetic Bacteria. Iran J Biotech. 2016;14(2):25–32. doi: 10.15171/IJB.1259
  18. Uraskulova BB, Gyusan AO. The clinical and bacteriological study of the effectiveness of the application of silver nanoparticle for the treatment of tuberculosis. Bulletin of otorhinolaryngology. 2017;82(3):54–57. (In Russ.) doi: 10.17116/otorino201782354-57
  19. Selim A, Tlhaig MM, Taha SA, Nasr EA. Antibacterial activity of silver nanoparticles against field and reference strains of Mycobacterium tuberculosis, Mycobacterium bovis and multiple-drug-resistant tuberculosis strains. Rev Sci Tech Off Int Epiz. 2018;37(3):823–830. doi: 10.20506/rst.37.3.2888
  20. Zakharov AV, Khokhlov AL. The results of experimental studies of the use of silver nanoparticles in tuberculosis drug-resistant pathogen. Medical news of north Caucasus. 2019;14(1–2):195–199. (In Russ.) doi: 10.14300/mnnc.2019.14013
  21. Zаkhаrov AV, Ergeshov AE, Khokhlov AL, Kibrik BS. Effectiveness of combination of isoniazid and silver nanoparticles in the treatment of experimental tuberculosis. Tuberculosis and Lung Diseases. 2017;95(6):51–58. (In Russ.) doi: 10.21292/2075-1230-2017-95-651-58
  22. Jafari A, Pourakba RL, Farhadi K, et al. Biological synthesis of silver nanoparticles and evaluation of antibacterial and antifungal properties of silver and copper nanoparticles. Turk J Biol. 2015;39:556–561. doi: 10.3906/biy-1406-81
  23. Maquiaveli CC, Rochetti AL, Fukumasu H, et al. Antileishmanil activity of verbascoside: Selective arginase inhibition of intracellular amastigotes of Leishmania (Leishmania) amazonensis with resistance induced by LPS plus IFN-γ. Biochem Pharmacol. 2017;127:28–33. doi: 10.1016/j.bcp.2016.12.018
  24. Lourdes CS, Brito LL, Bezerra TT, et al. Silver and gold nanoparticles from tannic acid: synthesis, characterization and evaluation of antileishmanial and cytotoxic activities. An Acad Bras Cienc. 2017;90(3):2679–2689. doi: 10.1590/0001-3765201820170598
  25. Keerthiga N, Anitha R, Rajeshkumar S, Lakshmi T. Antioxidant Activity of Cumin Oil Mediated Silver Nanoparticles. Pharmacogn J. 2019;(11):787–789. doi: 10.5530/pj.2019.11.125
  26. Saratale RG, Benelli G, Kumar G, et al. Biofabrication of silver nanoparticles using the leaf extract of an ancient herbal medicine, dandelion (Taraxacum officinale), evaluation of their antioxidant, anticancer potential, and antimicrobial activity against phytopathogens. Environ Sci Pollut Res. 2018;25:10392–10406. doi: 10.1007/s11356-017-9581-5
  27. Kuppusamy P, Ichwan SJ, Al-Zikri PN, et al. In Vitro Anticancer Activity of Au, Ag Nanoparticles Synthesized Using Commelina nudiflora L. Aqueous Extract Against HCT-116 Colon Cancer Cells. Biol Trace Elem Res. 2016;173:297–305. doi: 10.1007/s12011-016-0666-7
  28. El-Naggar NE, Hussein MH, El-Sawah AA. Bio-fabrication of silver nanoparticles by phycocyanin, characterization, in vitro anticancer activity against breast cancer cell line and in vivo cytotoxicity. Sci Rep. 2017;7:10844. doi: 10.1038/s41598-017-11121-3
  29. Rathi Sre PR, Reka M, Poovazhagi R, et al. Antibacterial and cytotoxic effect of biologically synthesized silver nanoparticles using aqueous root extract of Erythrina indica lam. Spectrochim Acta Part A. Mol Biomol Spectrosc. 2015;135:1137–1144. doi: 10.1016/j.saa.2014.08.019
  30. Govindaraju K, Krishnamoorthy K, Alsagaby SA, et al. Green synthesis of silver nanoparticles for selective toxicity towards cancer cells. IET Nanobiotechnol. 2015;9(6):325–330. doi: 10.1049/iet-nbt.2015.0001
  31. Alsalhi MS, Devanesan S, Alfuraydi AA, et al. Green synthesis of silver nanoparticles using Pimpinella anisum seeds: antimicrobial activity and cytotoxicity on human neonatal skin stromal cells and colon cancer cells. Int J Nanomedicine. 2016;11:4439–4449. doi: 10.2147/IJN.S113193
  32. Vijayan R, Joseph S, Mathew B. Indigofera tinctoria leaf extract mediated green synthesis of silver and gold nanoparticles and assessment of their anticancer, antimicrobial, antioxidant and catalytic properties. Artif Cells Nanomed Biotechnol. 2018;46:861–871. doi: 10.1080/21691401.2017.1345930
  33. Oh KH, Soshnikova V, Markus J, et al. Biosynthesized gold and silver nanoparticles by aqueous fruit extract of Chaenomeles sinensis and screening of their biomedical activities. Artif Cells Nanomed Biotechnol. 2018;46:599–606. doi: 10.1080/21691401.2017.1332636
  34. Yakop F, Abd Ghafar SA, Yong YK, et al. Silver nanoparticles Clinacanthus Nutans leaves extract induced apoptosis towards oral squamous cell carcinoma cell lines. Artif Cells Nanomed Biotechnol. 2018;46(2):131–139. doi: 10.1080/21691401.2018.1452750
  35. Saleh T, Ahmed E, Yu L, et al. Silver nanoparticles improve structural stability and biocompatibility of decellularized porcine liver. Artif Cells Nanomed Biotechnol. 2018:46(2):273–284. doi: 10.1080/21691401.2018.1457037
  36. Niska K, Knap N, Kędzia A, et al. Capping Agent-Dependent Toxicity and Antimicrobial Activity of Silver Nanoparticles: An In Vitro Study. Concerns about Potential Application in Dental Practice. Int J Med Sci. 2016;13(10):772–782. doi: 10.7150/ijms.16011
  37. Shawky HA, Soha MB, Gihan AELB, et al. Evaluation of Clinical and Antimicrobial Efficacy of Silver Nanoparticles and Tetracycline Films in the Treatment of Periodontal Pockets. IOSR J Dental Med Sci. 2012;2(1):6–12. doi: 10.5923/j.ijmb.20120201.02
  38. Corrêa JM, Mori M, Sanches HL, et al. Silver nanoparticles in dental biomaterials. Int J Biomater. 2015;2015:1–9. doi: 10.1155/2015/485275
  39. Pérez-Díaz MA, Boegli L, James G, et al. Silver nanoparticles with antimicrobial activities against Streptococcus mutans and their cytotoxic effect. Mater Sci Eng C Mater Biol Appl. 2015;55:360–366. doi: 10.1016/j.msec.2015.05.036
  40. World Health Report 2008. Working together for health. Geneva, World Health Organization, 2008.
  41. Lem KW, Choudhury A, Lakhani AA, et al. Use of nanosilver in consumer products. Recent Pat Nanotechnol. 2012;6(1):60–72. doi: 10.2174/187221012798109318
  42. Hendrickson OD. Toxicity of nanosilver in intragastric studies: biodistribution and metabolic effects. Toxicology Letters. 2016;241:184–192. doi: 10.1016/j.toxlet.2015.11.018
  43. Wang Z, Xia T, Liu S. Mechanisms of nanosilver-induced toxicological effects: more attention should be paid to its sublethal effects. Nanoscale. 2015;7(17):7470–7481. doi: 10.1039/C5NR01133G
  44. Demin VA, Demin VF, Anciferova AA, et al. Modeling interorgan distribution and bioaccumulation of engineered nanoparticles (using the example of silver nanoparticles). Nanotechnologies in Russia. 2015;10(3–4):103–109. (In Russ.) doi: 10.1134/S1995078015020081
  45. Zaitseva NV, Zemlyanova MA, Zvezdin VN, et al. Toxicological evaluation of nano-sized colloidal silver in experiments on mice. Behavioral reactions, morphology of internals. Health risk analysis. 2015;(2):68–81. (In Russ.) doi: 10.21668/health.risk/2015.2.09
  46. Vlasov RV, Kade AKh, Baryshev MG, et al. Influence of chronic peroral administration of silver nanoparti-cles on the active processes of free radical oxidation in an experiment on rats. Modern Problems of Science and Education. Surgery. 2017;(2):24. (In Russ.)
  47. Gmoshinsky IV, Shipelin VA, Vorozhko IV, et al. Toxicological evaluation of colloidal nano-sized silver stabilized polyvinylpyrrolidone. III. Enzymological, biochemical markers, state of antioxidant defense system. Problems of nutrition. 2016;85(2):14–23. (In Russ.)
  48. Zaytseva NV, Zemlyanova MA, Zvezdin VN, et al. Toxicological evaluation of nanosized colloidal silver, stabilized with polyvinylpyrrolidone, in 92-day experiment on rats. II. Internal organs morphology. Problems of nutrition. 2016;85(1):47–55. (In Russ.)
  49. Shumakova AA, Shipelin VA, Sidorova YuS, et al. Toxicological evaluation of nanosized colloidal silver, stabilized with polyvinylpyrrolidone. I. Characterization of nanomaterial, integral, hematological parameters, level of thiol compounds and liver cell apoptosis. Problems of nutrition. 2015;84(6):46–57. (In Russ.)
  50. Sun C. Silver nanoparticles induced neurotoxicity through oxidative stress in rat cerebral astrocytes is distinct from the effects of silver ions. Neurotoxicology. 2015;52:210–221. doi: 10.1016/j.neuro.2015.09.007
  51. Gaillet S, Rouanet MJ. Silver nanoparticles: their potential toxic effects after oral exposure and underlying mechanisms – a review. Food and Chemical Toxicology. 2015;77:58–63. doi: 10.1016/j.fct.2014.12.019
  52. Korani M, Ghazizadeh E, Korani S, et al. Effects of silver nanoparticles on human health. Eur J Nanomed. 2015;7(1):51–62. doi: 10.1515/ejnm-2014-0032
  53. Chang BM, Pan L, Lin HH, Chang HC. Nanodiamond-supported silver nanoparticles as potent and safe antibacterial agents. Sci Rep. 2019;9(1):13164. doi: 10.1038/s41598-019-49675-z
  54. Marassi V, Di Cristo L, Smith SGJ, et al. Silver nanoparticles as a medical device in healthcare settings: a five-step approach for candidate screening of coating agents. R Soc Open Sci. 2018;5(1):171113. doi: 10.1098/rsos.171113
  55. Ansari MA, Khan HM, Khan AA, et al. Anti-biofilm efficacy of silver nanoparticles against MRSA and MRSE isolated from wounds in a tertiary care hospital Indian. J Med Microbiol. 2015;33(1):101–109. doi: 10.4103/0255-0857.148402

Statistics

Views

Abstract: 151

PDF (Russian): 1

Dimensions

Article Metrics

Metrics Loading ...

PlumX


Copyright (c) 2021 Morozova Y.A., Dergachev D.S., Subotyalov M.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies